Cargando...
Immunotherapy for Esophageal Squamous Cell Carcinoma
Esophageal squamous cell carcinoma have been frustrating to treat, with slow progress made on extending survival. Immunotherapy targeting immune checkpoints, T cells, and infiltrating lymphocytes has shown promise in early studies. The efficacy of pembrolizumab and nivolumab is encouraging. Anti-che...
Gardado en:
| Publicado en: | Curr Oncol Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5374168/ https://ncbi.nlm.nih.gov/pubmed/28361224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0590-9 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|